$APTO Aptose Biosciences Inc. Insider Trading
Get free email notifications about insider trading in Aptose Biosciences Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aptose Biosciences Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aptose Biosciences Inc. for free.
CIK Number: 0000882361
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: APTO
Company Address: 251 CONSUMERS ROAD SUITE 1105 TORONTO M2J 4R3
Phone number: 416-798-1200
Former name: IMUTEC CORP, date of change: 1995-07-26
Former name: RML MEDICAL LABORATORIES INC, date of change: 1992-09-21
Former name: IMUTEC PHARMA INC, date of change: 1997-01-13
Former name: IMUTEC PHARMA INC, date of change: 1997-01-13
Former name: IMUTEC PHARMA INC, date of change: 1997-01-13
Former name: LORUS THERAPEUTICS INC, date of change: 1999-03-08
Former name: Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.), date of change: 2014-09-05
Aptose Biosciences Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2021 | APTO | Aptose Biosciences ... | Whitehead Warren | Director | Option Exercise | A | 4.38 | 50,000 | 219,000 | 50,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Vincent Mark D. | Director | Option Exercise | A | 4.38 | 50,000 | 219,000 | 50,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Rice William G. | Chair, President & ... | Option Exercise | A | 4.37 | 343,000 | 1,498,910 | 343,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Marango Jotin | Senior VP, Chief Bu ... | Option Exercise | A | 4.37 | 343,000 | 1,498,910 | 343,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Loewy Caroline M | Director | Option Exercise | A | 4.37 | 50,000 | 218,500 | 50,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Chow Gregory K. | Executive VP & CFO | Option Exercise | A | 4.37 | 343,000 | 1,498,910 | 343,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | BURGER DENIS R | Director | Option Exercise | A | 4.37 | 50,000 | 218,500 | 50,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | BURGER DENIS R | Director | Option Exercise | A | 4.37 | 50,000 | 218,500 | 50,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Bejar Rafael | Sr. VP, Chief Medic ... | Option Exercise | A | 4.37 | 343,000 | 1,498,910 | 343,000 | |
Jan 06 2021 | APTO | Aptose Biosciences ... | Ashe Carol Gail | Director | Option Exercise | A | 4.37 | 50,000 | 218,500 | 50,000 | |
Dec 28 2020 | APTO | Aptose Biosciences ... | Whitehead Warren | Director | Option Exercise | M | 2.01 | 20,000 | 40,200 | 20,000 | |
Dec 28 2020 | APTO | Aptose Biosciences ... | Whitehead Warren | Director | Sell | S | 4.11 | 10,000 | 41,100 | 40,000 | 50 K to 40 K (-20.00 %) |
Dec 28 2020 | APTO | Aptose Biosciences ... | Whitehead Warren | Director | Sell | S | 4.01 | 10,000 | 40,100 | 50,000 | 60 K to 50 K (-16.67 %) |
Dec 28 2020 | APTO | Aptose Biosciences ... | Whitehead Warren | Director | Buy | M | 2.01 | 20,000 | 40,200 | 60,000 | 40 K to 60 K (+50.00 %) |
Jul 10 2020 | APTO | Aptose Biosciences ... | Chow Gregory K. | Executive VP & CFO | Sell | S | 6.05 | 126,668 | 766,341 | 232,846 | 359.5 K to 232.8 K (-35.23 %) |